← All organizations
Gossamer Bio Inc.
For profitWebsite ↗
Also known as: GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc. | GB002, Inc. | GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. | GB004, Inc. | GB005, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. | GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. | Gossamer Bio Inc.
Highest phase reached
Phase 3
First clinical trial
Sep 4, 2017Last known activity
Dec 31, 2025
Timeline
2010s
- Jun 1, 2015
Gossamer Bio Inc.— Founded
Drugs by trial phase (8 distinct, 13 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (7 own, 0 via acquisition)
Indications
Recent trials (20)
- NCT07181382Lead sponsorPhase 3Dec 31, 2025
- NCT07181382OfficialPhase 3Dec 31, 2025
- NCT06274801Lead sponsorPhase 3Sep 3, 2024
- NCT06274801OfficialPhase 3Sep 3, 2024
- NCT05934526Lead sponsorPhase 3Sep 30, 2023
- NCT05934526Study directorPhase 3Sep 30, 2023
- NCT05242146Lead sponsorPhase 1/Phase 2May 24, 2022
- NCT05242146Study directorPhase 1/Phase 2May 24, 2022
- NCT04816604Lead sponsorPhase 2Apr 5, 2021
- NCT04816604Study directorPhase 2Apr 5, 2021
- NCT04456998Lead sponsorPhase 2Dec 14, 2020
- NCT04456998Study directorPhase 2Dec 14, 2020
- NCT04556383Lead sponsorPhase 2Oct 19, 2020
- NCT04556383Study directorPhase 2Oct 19, 2020
- NCT04060342Lead sponsorPhase 1/Phase 2Jul 25, 2019
Details
- Founded
- San Diego, CA, US Jun 1, 2015
- Last known activity
- Dec 31, 2025